Proceedings from the 9th Annual Meeting of International Society for Medical Publication Professionals Roundtable Session: key insights

Abstract

Introduction

During the 9th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP, April 29–May 1, 2013 in Baltimore, MD), ∼650 participants attended two of 13 available roundtable sessions. Participants included medical publication professionals from industry, communication agencies, and journals.

Discussion topics

Roundtable participants discussed how to best interpret and implement various guidances, such as Good Publication Practices 2 (GPP2), the International Committee of Medical Journal Editors (ICMJE) guidelines, and the Physician Payment Sunshine Act. The impact of and compliance with Corporate Integrity agreements (CIAs) on medical publication planning practices was debated. Roundtable participants also discussed ways of advancing both advocacy for the medical publication professional field and internal and external collaborations. The development of review manuscripts, publications from regions newly emerging in publication planning, medical devices publications, and real-world experience publications were discussed. Participants also considered the benefits and uncertainties of new technologies in medical publications such as multimedia and social media.

Summary

This is the first ever article to be published following the well-attended ISMPP roundtable sessions. The objective of this manuscript is to summarize key learnings that will aid continued discussions about challenges and opportunities facing medical publication professionals.

Keywords::

• Publication management
• Publication planning
• Medical publication professional

Transparency

Declaration of funding

The ISMPP Roundtable Session was supported by an educational grant from Synchrony Healthcare Group, LLC, West Chester, PA, USA.

Declaration of financial/other relationships

D.S. is an employee of Cadence Pharmaceuticals, the chair for the ISMPP U committee (2013–2014), and an ISMPP workshop presenter (Alliance Partners and Publication Planning, and Management at Smaller Pharmaceutical/Biotechnology Companies). R.J. is an employee and stockholder of Novo Nordisk Inc. G.N.S. is an employee of Envision Pharma Group. K.S. is an employee of Novartis Pharmaceuticals Corporation. C.W.-H. is an employee of the International Society of Medical Publication Professionals. CMRO Peer Reviewers on this manuscript have no relevant financial relationships to disclose, but have disclosed that they are former members of ISMPP.

Acknowledgments

This report summarizes the discussions from the ISMPP 9th Annual roundtable session and does not represent the opinions of the authors or their previous or current employers. The authors thank Jennifer Ciafullo, MPH, from ISMPP for her invaluable support in developing these roundtable session topics and Sheryl Weinerman of Envision Pharma Group for editorial and formatting support. The authors also thank the Roundtable Moderators: Bea Benoit, Tim Day, Martin Delahunty, Amy Foreman-Wykert, Art Gertel, John Gonzalez, Jackie Gordon, Courtney Leo, Thomas Maliecka, Robert Matheis, Bryce McMurray, Julie Newman, Robert Norris, Kirtida Pandya, Mina Patel, Teresa Peña, Kim Pepitone, Michael Platt, Carol Sanes-Miller, Brian Scheckner, Anca Serban, Beth Sesler, Rachel Sherman, Danita Sutton, Stephanie Tortell, Russell Traynor, Al Weigel, Susan Wingeron, Karen Woolley, and Yvonne Yarker.